Tag: chronic pain

Pain Expert to Discuss Osteoarthritis Trials at APS 2018

DURHAM, N.C., MARCH 2, 2018 — You know that well-worn advice about picking investments: that past performance doesn’t guarantee future results. The same can be said of selecting clinical trial sites, as Premier Research’s top analgesia expert will explore at the American Pain Society’s 2018 Scientific Summit on March 6 in Anaheim. Michael Kuss, Vice...

Clinical Research: Phase 1 - Phase 4

The ABC’s of OA

Chances are you’ve either personally dealt with osteoarthritis (OA) or know someone who has. This common type of degenerative joint pain represents both a heavy disease burden and a major opportunity for drug developers. Read on to learn more about: OA’s prevalence Optimal diagnostic criteria for clinical trials Treatment options What OA research looks like...

Clinical Research: Phase 1 - Phase 4

Chronic Pain: Conducting Clinical Trials In Osteoarthritis

It’s the leading cause of disability due to pain and the most common form of arthritis, afflicting an estimated 237 million people worldwide. Osteoarthritis (OA) occurs as the cartilage on the end of bones wears down and most often affects the hands, knees, hips, and spine – though it can damage any joint in the...

Clinical Research: Phase 1 - Phase 4

Six Insights To Treating Fibromyalgia

The journey to treating fibromyalgia has taken a sometimes circuitous path. After a burst of activity about a decade ago, the pursuit of new therapies took a years-long pause before reigniting in recent years. In the past five years, we’ve performed 16 fibromyalgia clinical trials (more than any other CRO), and here are some reflections...

Consulting

Rushing Site Selection in Fibromyalgia Trials, Not a Great Idea

In the early days of fibromyalgia drug research, trial site selection centered almost exclusively on rheumatologists and pain centers. But with more drugs on the market and still more studies underway, there has been significant expansion in the number of sites equipped to conduct this research. Up to a point, anyway. As fibromyalgia therapy matures,...

Data Management & Biostatistics

ASA Biopharmaceutical Workshop to Explore Study of Chronic Pain

DURHAM, N.C., SEPTEMBER 29, 2016 — Point-in-time “landmark” analysis, the standard in most chronic pain studies, may not be appropriate for evaluating single-dose drugs. Instead, an analysis strategy similar to that used in acute-pain research may be more effective, Premier Research’s top biostatistics expert will assert in a poster presentation at the American Statistical Association’s...